Search research articles
Contact Us
Filters
Showing results (441-450 of 470) with videos related to
Page
of 47
Sort By:
Nature Cancer
|
December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers
Marc Payton, Brian Belmontes, Kelly Hanestad, et al.
Molecular Cancer Therapeutics
|
December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress
Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Cancer Discovery
|
September 2, 2025
Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex
Linjie Yuan, Wenzhi Ji, Brendan G Dwyer, et al.
Cancer Research
|
February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
Thomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Molecular Cancer Research : MCR
|
August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
Elizabeth H Stover, Maria B Baco, Ofir Cohen, et al.
Cell Reports
|
August 29, 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors
Elaine M Oberlick, Matthew G Rees, Brinton Seashore-Ludlow, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolism
Keene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletions
Linda Julian, Lisa Crozier, Devon Lukow, et al.
Nature Communications
|
December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Cell Chemical Biology
|
September 9, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolism
Keene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Page
of 47
Search research articles
Search
Showing results (441-450 of 470) with videos related to
Sort By:
Page
of 47
Nature Cancer
|
December 27, 2023
Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers
Marc Payton, Brian Belmontes, Kelly Hanestad, et al.
Molecular Cancer Therapeutics
|
December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress
Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Cancer Discovery
|
September 2, 2025
Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex
Linjie Yuan, Wenzhi Ji, Brendan G Dwyer, et al.
Cancer Research
|
February 14, 2019
MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors
Thomas P Howard, Taylor E Arnoff, Melinda R Song, et al.
Molecular Cancer Research : MCR
|
August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
Elizabeth H Stover, Maria B Baco, Ofir Cohen, et al.
Cell Reports
|
August 29, 2019
Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors
Elaine M Oberlick, Matthew G Rees, Brinton Seashore-Ludlow, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolism
Keene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
On-target toxicity limits the efficacy of CDK11 inhibition against cancers with 1p36 deletions
Linda Julian, Lisa Crozier, Devon Lukow, et al.
Nature Communications
|
December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Cell Chemical Biology
|
September 9, 2023
Screening in serum-derived medium reveals differential response to compounds targeting metabolism
Keene L Abbott, Ahmed Ali, Dominick Casalena, et al.
Page
of 47